AR072686A1 - Colirio para la prevencion o para el tratamiento de la astenopia acomodativa - Google Patents

Colirio para la prevencion o para el tratamiento de la astenopia acomodativa

Info

Publication number
AR072686A1
AR072686A1 ARP090102495A ARP090102495A AR072686A1 AR 072686 A1 AR072686 A1 AR 072686A1 AR P090102495 A ARP090102495 A AR P090102495A AR P090102495 A ARP090102495 A AR P090102495A AR 072686 A1 AR072686 A1 AR 072686A1
Authority
AR
Argentina
Prior art keywords
prevention
treatment
collirio
astenopia
accomodative
Prior art date
Application number
ARP090102495A
Other languages
English (en)
Inventor
Nicola Pescosolido
Aleardo Koverech
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of AR072686A1 publication Critical patent/AR072686A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe el colirio y el uso de L-carnitina, en combinacion con antioxidantes tales como la vitamina E y elementos inorgánicos tales como manganeso, zinc, sodio y potasio, para la preparacion de un suplemente fisiologico o medicamento de uso oftálmico, para la prevencion o para el tratamiento de la astenopía acomodativa.
ARP090102495A 2008-07-04 2009-07-03 Colirio para la prevencion o para el tratamiento de la astenopia acomodativa AR072686A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08159676 2008-07-04

Publications (1)

Publication Number Publication Date
AR072686A1 true AR072686A1 (es) 2010-09-15

Family

ID=39968069

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090102495A AR072686A1 (es) 2008-07-04 2009-07-03 Colirio para la prevencion o para el tratamiento de la astenopia acomodativa

Country Status (14)

Country Link
US (2) US20110268817A1 (es)
EP (1) EP2303256A1 (es)
JP (1) JP5555693B2 (es)
KR (1) KR20110025824A (es)
CN (2) CN104688718A (es)
AR (1) AR072686A1 (es)
AU (1) AU2009265841A1 (es)
BR (1) BRPI0913909A2 (es)
CA (1) CA2729708A1 (es)
EA (1) EA201170138A1 (es)
MX (1) MX2010013439A (es)
SG (1) SG191700A1 (es)
TW (1) TWI474817B (es)
WO (1) WO2010000661A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180042978A1 (en) * 2008-04-10 2018-02-15 U.S. Nutraceuticals, Llc D/B/A Valensa International Method of treating photo-induced ocular fatigue and associated reduction in speed of ocular focus
CN110772604A (zh) * 2019-11-05 2020-02-11 何少明 一种护眼明目喷剂及其加工工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040058015A1 (en) * 2000-06-01 2004-03-25 Yuanjin Tao Compositions and methods for treating eye discomfort and eye disease
US7029712B1 (en) * 2002-07-17 2006-04-18 Biosyntrx Inc Treatment for dry eye syndrome
CA2611909C (en) * 2005-07-01 2014-01-07 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Composition for treatment of corneal disease
WO2007006672A1 (en) * 2005-07-08 2007-01-18 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of a combination comprising l-carnitine or alkanoyl l-carnitine, lipid solubl benzoquinone and omega-3-polyunsaturated fatty acid for the preparation of a dietary supplement or medicament for the treatment of corneal diseases
EP2101725A1 (en) * 2006-12-14 2009-09-23 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye drops
BRPI0720434A2 (pt) * 2006-12-22 2014-01-07 Sigma Tau Ind Farmaceuti Gel útil para liberação de fármacos oftálmicos

Also Published As

Publication number Publication date
WO2010000661A1 (en) 2010-01-07
SG191700A1 (en) 2013-07-31
MX2010013439A (es) 2011-01-21
CA2729708A1 (en) 2010-01-07
TWI474817B (zh) 2015-03-01
CN102076336A (zh) 2011-05-25
JP2011526587A (ja) 2011-10-13
US20110268817A1 (en) 2011-11-03
CN104688718A (zh) 2015-06-10
TW201010694A (en) 2010-03-16
US20140079809A1 (en) 2014-03-20
BRPI0913909A2 (pt) 2015-10-13
KR20110025824A (ko) 2011-03-11
EA201170138A1 (ru) 2011-06-30
AU2009265841A1 (en) 2010-01-07
JP5555693B2 (ja) 2014-07-23
EP2303256A1 (en) 2011-04-06

Similar Documents

Publication Publication Date Title
DOP2011000285A (es) 2-acetamido-5-aril-1, 2, 4-triazolonas sustituidas y su uso
CU20120161A7 (es) 5-fluoro-1h-pirazolopiridinas sustituidas
CR20150232A (es) Imidazo [1,2-a] piridincarboxamidas aminosustituidas y su uso
MX367861B (es) Una composición nutricional para usarse en la preservación del músculo esquelético.
BR112014013175A2 (pt) composições de liberação prolongada baseadas em lipídios anfipáticos
MY171920A (en) Prevention and treatment of ocular conditions
UY30364A1 (es) Arilimidazolonas y ariltriazolonas sustituidas asi como su uso
ECSP099516A (es) Composición suplementaria nutricional para el tratamiento de enfermedades oculares
WO2013103919A8 (en) Compositions and methods for treating metabolic disorders
WO2012156296A8 (en) Pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients
CL2010001406A1 (es) Composicion farmaceutica oftalmica que comprende povidona yodada, y un compuesto antiinflamatorio esteroidal, un compuesto antiinflamatorio no esteroidal, un antibacteriano, un antialergico o un compuesto antiglaucoma; y metodo para preservar la composicion.
BR112013029256A2 (pt) "combinações farmacêuticas para uso no tratamento de pacientes com diabetes tipo 2, método de tratamento, e usos de lixisenatida e metformina".
CL2008002747A1 (es) Compuestos derivados de furo y tienopirimidina; composicion farmaceutica; metodo para modular la actividad del receptor de histamina h4; y uso en el tratamiento de trastornos tales como inflamacion, trastornos alergicos, dermatologicos, entre otros.
BR112013011259A2 (pt) condições de tratamento associadas com nível aumentado de eotaxina com 25-hidroxivitamina d3
EA201201239A1 (ru) Композиция, содержащая в качестве активного ингредиента l-карнитин в комбинации с гидроксикинуренин-о-бета-dl-глюкозидом, для предотвращения и/или лечения патологий глаза, вызванных ультрафиолетовым излучением
AR086395A1 (es) Envase para el tratamiento de patologias
GT201400161A (es) Fenilimidazopirazoles sustituidos y su uso
UY33153A (es) Formulación tópica oftálmica de péptidos
AR072686A1 (es) Colirio para la prevencion o para el tratamiento de la astenopia acomodativa
GT200900006A (es) Derivados de piridazina novedosos
CO6450623A2 (es) Parasiticidas sanguineos
AR089615A1 (es) Peptidos antimicrobianos, composiciones que los comprenden y usos
CO6602160A2 (es) Terapia de b12 oral
IN2012DN03631A (es)
UA44395U (ru) Применение тиоцетама в качестве диуретического средства с мягким мочегонным действием в комплексном лечении

Legal Events

Date Code Title Description
FB Suspension of granting procedure